Companies · Other Health Care

Cardia, Inc.

Eagan · Other Health Care

Diligence memoA one-page analyst read on Cardia, Inc. — recommendation, valuation, rhythm, risks.
$6.2M
Total raised · real
8
Rounds
0.6×
Latest step-up
Top 33%
Sector rank · raised
Seed
Latest stage · inferred · Wed Nov 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Cardia, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.25× the median modeled value of Seed Other Health Care companies in 2019–2021 (211 peers) — value vs value, same stage and era.
Dormant
  • Last raise 6.6 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Cardia, Inc. is one of 5376 Other Health Care companies tracked from Eagan. By capital raised it ranks mid-pack (ahead of 68% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
8
Investors (latest)
2019-11-13
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2011-07-25 Raised $2.1M (real) Modeled valuation $52M (est)Seed2011Seed · 2012-10-22 Raised $1.2M (real) Modeled valuation $31M (est)Seed2012Seed · 2013-05-04 Raised $400K (real) Modeled valuation $9.9M (est)Seed2013Seed · 2013-06-28 Raised $550K (real) Modeled valuation $14M (est)Seed2013Seed · 2013-07-01 Raised $550K (real) Modeled valuation $14M (est)Seed2013Seed · 2015-06-02 Raised $250K (real) Modeled valuation $6.2M (est)Seed2015Seed · 2016-06-23 Raised $750K (real) Modeled valuation $19M (est)Seed2016Seed · 2018-02-20 Raised $600K (real) Modeled valuation $15M (est)Seed2018Seed · 2019-11-13 Raised $364K (real) Modeled valuation $9.0M (est)Seed2019+$1.2M+$400K+$550K+$550K+$250K+$750K+$600K+$364KCumulative $6.8M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.1M · 2011
Seed extension$1.2M · 2012
Seed extension$400K · 2013
Seed extension$550K · 2013
Seed extension$550K · 2013
Seed extension$250K · 2015
Seed extension$750K · 2016
Seed extension$600K · 2018
Seed extension$364K · 2019

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$9.0M
Base estimate est.
$308K
Conservative case
$70.9M
Upside case
$1.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $51.6M · 2011-07-252011Seed · modeled $30.9M · 2012-10-22Seed · modeled $9.9M · 2013-05-04Seed · modeled $13.6M · 2013-06-28Seed · modeled $13.6M · 2013-07-01Seed · modeled $6.2M · 2015-06-02Seed · modeled $18.6M · 2016-06-23Seed · modeled $14.9M · 2018-02-20Seed · modeled $9.0M · 2019-11-132019
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
6.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
12 mo
Avg between rounds
$752K/yr
Capital velocity
14.9 yr
On record since
2011
First round
9
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.6× above median
This company$6.2M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.2× of median
This company$364K
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.4× of median
This company$9.0M
Sector median$22.1M

Raised more than 68% of sector peers (real $). Modeled value above 32% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #192 of 211.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Crossroads at Delta Memory · Seed Raised $4.3M · modeled $99.1M (est)Noninvasix, Inc. · Seed Raised $4.0M · modeled $97.9M (est)CPIV Haven Holdings, LLC · Seed Raised $3.8M · modeled $92.9M (est)Cane Ip Key Holdings, Llc · Seed Raised $3.5M · modeled $87.4M (est)Hospi Corp · Seed Raised $7.0M · modeled $86.6M (est)Functional Fluidics Inc. · Seed Raised $3.6M · modeled $84.1M (est)Starling Solutions Inc. · Seed Raised $3.8M · modeled $82.1M (est)CairnSurgical, Inc. · Seed Raised $3.3M · modeled $81.5M (est)DxLab Inc. · Seed Raised $4.0M · modeled $81.4M (est)Freedom Center of Beacon, LLC · Seed Raised $3.2M · modeled $80.5M (est)GenomOncology, LLC · Seed Raised $5.8M · modeled $79.3M (est)Kingwood Surgicenter, LLC · Seed Raised $3.0M · modeled $74.7M (est)Cardia, Inc. (this company) Raised $6.2M · modeled $9.0M (est)Cardia, Inc.
CompanyStageRaised · realValue · estvs peer med.
Crossroads at Delta MemorySeed$4.3M$99.1M2.77×
Noninvasix, Inc.Seed$4.0M$97.9M2.74×
CPIV Haven Holdings, LLCSeed$3.8M$92.9M2.60×
Cane Ip Key Holdings, LlcSeed$3.5M$87.4M2.44×
Hospi CorpSeed$7.0M$86.6M2.42×
Functional Fluidics Inc.Seed$3.6M$84.1M2.35×
Starling Solutions Inc.Seed$3.8M$82.1M2.30×
CairnSurgical, Inc.Seed$3.3M$81.5M2.28×
DxLab Inc.Seed$4.0M$81.4M2.28×
Freedom Center of Beacon, LLCSeed$3.2M$80.5M2.25×
GenomOncology, LLCSeed$5.8M$79.3M2.22×
Kingwood Surgicenter, LLCSeed$3.0M$74.7M2.09×
Cardia, Inc. this companySeed$6.2M$9.0M0.25×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.1M2011-07-25$10.4M$51.6M85%
Seed$1.2M2012-10-22$6.2M$30.9M85%
Seed$400K2013-05-04$2.0M$9.9M85%
Seed$550K2013-06-28$2.8M$13.6M85%
Seed$550K2013-07-01$2.8M$13.6M85%
Seed$250K2015-06-02$1.3M$6.2M85%
Seed$750K2016-06-23$3.8M$18.6M85%
Seed$600K2018-02-20$3.0M$14.9M90%
Seed$364K2019-11-13$1.8M$9.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.1M2011-07-25
    • First recorded raise — entered as Seed.
    • 24 investors on this round.
  2. Seed$1.2M2012-10-22
    • Raised 15 mo later, in step with the ~14 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 11 investors on this round.
  3. Seed$400K2013-05-04
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 3.1× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  4. Seed$550K2013-06-28
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 1.4× larger than the prior — scaling up.
    • 2 investors on this round.
  5. Seed$550K2013-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  6. Seed$250K2015-06-02
    • Raised again after 23 mo — slower than the ~14 mo sector norm.
    • Round 2.2× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 1 investor on this round.
  7. Seed$750K2016-06-23
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 3.0× larger than the prior — scaling up.
    • 6 investors on this round.
  8. Seed$600K2018-02-20
    • Raised 20 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 11 investors on this round.
  9. Seed$364K2019-11-13
    • Raised again after 21 mo — slower than the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 8 investors on this round.
Intelligence
2020 ~Q4
Modeled next raise · ~12mo cadence
$364K
Modeled next size est.range $364K$583K
0.6×
Last step-up
$752K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Joseph A. Marino2 other2011-07
Christopher J Turnbull1 other2011-07
PETER M. BUONOMO2011-07
Registry & provenance

Cardia, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1074459
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
VBOX, Inc.Other Health CareSeed$5.3M$12.4Mnetwork1 shared operator · same sector · same stage
InClinica, Inc.Other Health CareSeed$5.7M$9.3Msame sector · same stage
Encore Medical, Inc.HealthtechSeed$1.3M$13.3Mnetwork2 shared operators · same stage
Pan-Am Acquisition, LLCOther Health CareSeed$5.5M$9.3Msame sector · same stage
ushealthrecord, inc.Other Health CareSeed$5.5M$7.6Msame sector · same stage
Kindbridge CorpOther Health CareSeed$5.4M$9.9Msame sector · same stage
TechniScan, Inc.Other Health CareSeed$5.3M$9.6Msame sector · same stage
Wavegate CorpOther Health CareSeed$5.2M$9.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Biocardia Lifesciences, Inc.Other Health CareSeries A$88.3M90%
CardioNXT, Inc.Other Health CareSeed$74.4M88%
Cardialen, Inc.Other Health CareSeries B$71.8M88%
Cardionomic, Inc.Other Health CareSeries B$76.2M87%
CardioWise, Inc.Other Health CareSeed$8.0M87%
VasoCardea, Inc.Other Health CarePre-Seed$24.4M87%
National Cardiac Inc.Other Health CarePre-Seed$17.9M86%
MedVirginia, Inc.Other Health CareSeed$12.4M86%
Frequently asked
How much funding has Cardia, Inc. raised?
Cardia, Inc. has raised approximately $6.2M in disclosed capital across 8 recorded financing rounds, aggregated from public filings.
What is Cardia, Inc.'s estimated valuation?
Provath's modeled valuation for Cardia, Inc. is approximately $9.0M (modeled range $308K–$70.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Cardia, Inc. at?
Cardia, Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Wed Nov 13.
What does Cardia, Inc. do and where is it based?
Cardia, Inc. operates in the Other Health Care sector, based in Eagan.
Explore related

See where Cardia, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Cardia, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.